about
Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancersA gene expression profile of stem cell pluripotentiality and differentiation is conserved across diverse solid and hematopoietic cancersTumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signallingMicroRNA let-7: an emerging next-generation cancer therapeuticHigher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIBA New Biological Feature of Natural Killer Cells: The Recognition of Solid Tumor-Derived Cancer Stem CellsYin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implicationAdvances in targeted and immunobased therapies for colorectal cancer in the genomic eraEndometrial stem cells: clinical application and pathological rolesThe Warburg effect and drug resistanceTargeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapyCommon stemness regulators of embryonic and cancer stem cellsUtilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy DeliveryIncreased Oxidative Stress as a Selective Anticancer TherapyCells of origin and tumor-initiating cells for nonmelanoma skin cancersThe Role of microRNAs in Stemness of Cancer Stem CellsSignificance of CD44 expression in head and neck cancer: a systemic review and meta-analysisTumor cells positive and negative for the common cancer stem cell markers are capable of initiating tumor growth and generating both progeniesPolycomb group protein Bmi1 is required for growth of RAF driven non-small-cell lung cancerRegulatory mechanisms of microRNAs in lung cancer stem cellsIn vitro models of cancer stem cells and clinical applicationsTargeted Cancer Therapy: Vital Oncogenes and a New Molecular Genetic Paradigm for Cancer Initiation Progression and TreatmentTargeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS/YAP1 signalingHepatocellular carcinoma: Where there is unmet needCD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating CellsThe variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesisThe cancer stem cell niche--there goes the neighborhood?Modification of mammalian reoviruses for use as oncolytic agentsFOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast CancerSal-like protein 4 (SALL4), a stem cell biomarker in liver cancersA simple mathematical model based on the cancer stem cell hypothesis suggests kinetic commonalities in solid tumor growthSmall molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancerKrüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cellsResponse of breast cancer cells and cancer stem cells to metformin and hyperthermia alone or combinedResveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/β-catenin signaling pathwayDe-differentiation confers multidrug resistance via noncanonical PERK-Nrf2 signalingSpheres derived from lung adenocarcinoma pleural effusions: molecular characterization and tumor engraftmentAn embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumorsDownregulation of miRNA-200c links breast cancer stem cells with normal stem cellsMolecular cues on obesity signals, tumor markers and endometrial cancer.
P2860
Q21562662-F800D792-53F0-4121-A510-6DE2B5A1D4B1Q21999537-3AE75E77-07B4-438E-87CE-46092E3D22BAQ24629299-24D9D729-E8BE-4C3A-8296-2189E637CE36Q24644251-B3C0E2CB-6E1D-44B9-91C5-1161B5117DDAQ24645020-7A7ACEBF-F8B0-436F-8FF4-DEC817790E22Q26744651-A1254D55-6B9A-4A29-8EF6-70F7B4D1D313Q26745972-C6BED7EB-D49D-49C0-AF06-3ACC8D411A56Q26751344-637AB3CB-D240-4E01-90B0-E75B6321C1DCQ26765287-BE176F98-EE90-4AF2-B1E7-D9714F32D943Q26770007-83151BD7-2A3C-4473-AA10-6B7FE7876F96Q26775961-6898D97E-1603-4401-BA7B-863D5C8BE937Q26777882-19B90691-6BDF-49D3-BD90-CF5D305B5E13Q26786070-D146FD16-BBA5-4F79-8944-36E368898841Q26798210-F56F23BF-4ED4-4B8E-B002-5A2FC28BF097Q26823028-DCE7997E-39ED-44FE-AB82-03CF651EBD82Q27005618-AAA7CB14-7DB6-4581-A2CA-1982236A5DEAQ27023399-54A07708-1289-4E89-A8AC-DA1CB3E4AFE6Q27318628-A9EFFCF6-A505-41E2-B6E2-07B1A2B02CEEQ27438119-08877830-FD76-49B9-92D7-0ADA4903B9AAQ28072716-6F09BE24-64B8-4F1D-B774-728FFCC55315Q28076101-5434D574-2DF8-41F6-B098-17B622C3A90BQ28076462-592F977E-6AEC-4A21-AE0D-3151C0E2EE82Q28078716-24F7B7AA-B20E-4FB7-926B-B563BFC33101Q28084046-66F4E529-8428-492E-99B1-608D255CFAB9Q28084610-AD59C2D7-26F1-48D2-9A83-68C9EFAA6EB0Q28119042-535BC14A-91FB-4316-BF92-75C7FFEBA3F0Q28244178-EAC599FD-38D7-4B80-BCB3-FF8860AEB2A2Q28264900-3EF7E3E2-DEB7-4F3A-A5FC-267B543BF675Q28269779-BA0B3DF1-6793-4BD4-8C1D-5CFA94D84D31Q28279753-DF4B5B20-FB51-461A-865E-72C5DE94D448Q28480928-7E12A2F1-5128-4733-AE0A-B7EBDC7C70E7Q28481728-83EEC5F0-BE11-41B9-8081-42319DE0EEEFQ28486138-17A61665-0BBC-4E16-B0F6-79E39BAEA042Q28539523-B6B7B837-6747-4400-8091-6FA6B698D5C6Q28541242-C3B0D3E5-1ECC-4F95-8107-44D5D8D87205Q28542879-6F0D09A5-A0BD-4180-8673-191CC4C985B0Q28742459-18A1B7CD-71E5-4ECD-9F8E-1577D6D42FD0Q29615393-E1583ADF-2F93-4487-BB6C-C35A61E0C049Q29619847-239B7743-E281-48F6-8F6C-194A69587AE6Q30372789-830FFEFE-609C-455D-920D-02E92F486757
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The biology of cancer stem cells.
@en
type
label
The biology of cancer stem cells.
@en
prefLabel
The biology of cancer stem cells.
@en
P2093
P1476
The biology of cancer stem cells.
@en
P2093
Dalong Qian
Michael F Clarke
Neethan A Lobo
P304
P356
10.1146/ANNUREV.CELLBIO.22.010305.104154
P577
2007-01-01T00:00:00Z